Top ▲
Target id: 2890
Nomenclature: lymphocyte antigen 96
Abbreviated Name: MD-2
Family: Lymphocyte antigens
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 160 | 8q21.11 | LY96 | lymphocyte antigen 96 | |
Mouse | - | 160 | 1 A3 | Ly96 | lymphocyte antigen 96 | |
Rat | - | 160 | 5 | Ly96 | lymphocyte antigen 96 |
Previous and Unofficial Names |
LPS co-receptor MD-2 | myeloid differentiation factor-2 | ESOP-1 |
Database Links | |
Alphafold | Q9Y6Y9 (Hs), Q9JHF9 (Mm) |
ChEMBL Target | CHEMBL2375202 (Hs), CHEMBL2384895 (Mm) |
Ensembl Gene | ENSG00000154589 (Hs), ENSMUSG00000025779 (Mm), ENSRNOG00000067966 (Rn) |
Entrez Gene | 23643 (Hs), 17087 (Mm), 448830 (Rn) |
Human Protein Atlas | ENSG00000154589 (Hs) |
KEGG Gene | hsa:23643 (Hs), mmu:17087 (Mm), rno:448830 (Rn) |
OMIM | 605243 (Hs) |
Pharos | Q9Y6Y9 (Hs) |
RefSeq Nucleotide | NM_015364 (Hs), NM_016923 (Mm), NM_001024279 (Rn) |
RefSeq Protein | NP_056179 (Hs), NP_058619 (Mm), NP_001019450 (Rn) |
UniProtKB | Q9Y6Y9 (Hs), Q9JHF9 (Mm) |
Wikipedia | LY96 (Hs) |
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Agonists | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Immunopharmacology Comments |
LY96 (MD2) is a binding partner of Toll-like receptor 4 (TLR4), required to initiate an innate immune response to bacterial lipopolysaccharide (LPS). The signaling complex also contains CD14 co-receptor [1]. LY96 is an important therapeutic target for inflammatory disorders. |
Immuno Process Associations | ||
|
||
|
||
|
||
|
General Comments |
ChEMBL target CHEMBL3038513 is the complex of human LY96 and Toll-like receptor 4 (TLR4). |
1. Kitchens RL. (2000) Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol, 74: 61-82. [PMID:10608082]
2. Wang Y, Shan X, Chen G, Jiang L, Wang Z, Fang Q, Liu X, Wang J, Zhang Y, Wu W et al.. (2015) MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis. Br J Pharmacol, 172 (17): 4391-405. [PMID:26076332]
3. Wang Y, Su L, Morin MD, Jones BT, Whitby LR, Surakattula MM, Huang H, Shi H, Choi JH, Wang KW et al.. (2016) TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS. Proc Natl Acad Sci USA, 113 (7): E884-93. [PMID:26831104]
Lymphocyte antigens: lymphocyte antigen 96. Last modified on 30/05/2017. Accessed on 11/12/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2890.